Case Report: Differential diagnosis and clinical management of isolated prolonged activated partial thromboplastin time. [PDF]
Liu L, Guo D.
europepmc +1 more source
Effect of Hyperthermia on Prothrombin Time (PT), International Normalized Ratio (INR), and Activated Partial Thromboplastin Time (APTT). [PDF]
Devi J, Kakkar N, Sharma A.
europepmc +1 more source
Effect of emicizumab-neutralizing antibodies on activated partial thromboplastin time-based clotting time test results in patients treated with emicizumab. [PDF]
Novembrino C +4 more
europepmc +1 more source
Association between activated partial thromboplastin time and septic shock in pregnant women: a retrospective cohort study. [PDF]
Zheng S, Chen D, Gao Y.
europepmc +1 more source
Evaluation of Prothrombin Time and Activated Partial Thromboplastin Time in Antithrombotic-Treated Cardiac Patients: A Cross-Sectional Study from Sana'a City, Yemen. [PDF]
Amer AH, Al-Adhroey AH, Al-Shammakh AA.
europepmc +1 more source
Normalization of activated partial thromboplastin time and diluted Russell's viper venom time ratios can be safely omitted in the assessment of lupus anticoagulant. [PDF]
Kimiaei A, Antovic J, Gran C.
europepmc +1 more source
Comparative analysis on characteristics of two activated partial thromboplastin time reagents. [PDF]
Yasui Y, Ishii T, Tatebe J, Morita T.
europepmc +1 more source
Identifying the silent deficiency: Severe Factor XI deficiency in an asymptomatic patient with isolated prolonged activated partial thromboplastin time-A case report. [PDF]
Alshurafa A +4 more
europepmc +1 more source
Activated Partial Thromboplastin Time and Mortality in Coronary Artery Bypass Grafting Patients. [PDF]
Zhang H, Tian W, Qi G, Sun L, Wei X.
europepmc +1 more source

